DeepPsy raises CHF 2 M

DeepPsy extracts depression-related biomarkers from EEG and ECG to help clinicians choose a treatment. The Swiss National Science Foundation is granting CHF 1.99 million to PRECISE MDD, a randomised trial of 500 patients evaluating DeepPsy's approach, led by an independent academic consortium.

Announced on
Round
Grant
Amount
CHF 2 M
Location
canton of Zurich
Sector
Health & medtech

Investors

  • Fonds national suisse (FNS) lead

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic